(Q52863383)

9 May 2018

title

ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. (English)

1 reference

9 May 2018

1 reference

D Ash

1

1 reference

9 May 2018

A Flynn

2

1 reference

9 May 2018

J Battermann

3

1 reference

9 May 2018

T de Reijke

4

1 reference

9 May 2018

P Lavagnini

5

1 reference

9 May 2018

L Blank

6

1 reference

9 May 2018

ESTRA/EAU Urological Brachytherapy Group

7

1 reference

9 May 2018

EORTC Radiotherapy Group

8

1 reference

9 May 2018

publication date

1 December 2000

1 reference

9 May 2018

Radiotherapy and Oncology

published in

1 reference

9 May 2018

volume

57

1 reference

9 May 2018

issue

3

1 reference

9 May 2018

page(s)

315-321

1 reference

9 May 2018

Short-term morbidity from CT-planned transperineal I-125 prostate implants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Adjuvant hormonal treatment with radiotherapy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

A simple method to stabilize the prostate during transperineal prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Improvement in dosimetry of ultrasound-guided prostate implants with the use of multiple stabilization needles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Complications of 125 Iodine Implantation and Pelvic Lymphadenectomy in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Cell kinetic measurements in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

A survey of current clinical practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Guided brachytherapy for treatment of confined prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

CT-based optimized planning for transperineal prostate implant with customized template

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

A CT-based evaluation method for permanent implants: application to prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

An improved method for computerized tomography-planned transperineal 125iodine prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900306-6

7 January 2021

10.1016/S0167-8140(00)00306-6

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018